Introduction
When avoiding a food changes the risk
For years, parents were told to delay peanuts to prevent allergy. Then a striking difference between British and Israeli children helped overturn that advice. Treating an existing allergy, though, requires a very different calculation.
Chapter 1: A different future
An allergic immune system can learn
Food allergy care has expanded beyond keeping dangerous foods out of reach. Immunotherapy exposes an allergic person to carefully measured amounts of an allergen under medical supervision, aiming to increase how much they can tolerate. Kari Nadeau brings the perspective of a Stanford physician-researcher; Sloan Barnett brings her experience taking two children through clinical trials.
Their motivation is concrete. Barnett drove ninety minutes to Stanford each week for one child or the other to have a treatment dose increased. Nadeau’s early combination study of milk immunotherapy and omalizumab involved just eleven patients, yet showed that some could tolerate much more milk after treatment.
The vocabulary sets the limits of the promise. Desensitization often depends on continued exposure. Sustained unresponsiveness means protection persists through a measured period without treatment. Neither establishes a lifelong cure. Published in 2020, the book captures a changing treatment landscape; its regulatory details and experimental options describe that period, rather than current clinical guidance.
Takeaway
A higher reaction threshold can change daily life even when lifelong freedom from allergy remains unproven.